Maxderm s.r.o.

The medical center is at the forefront of pediatric dermatology, focusing on innovative treatments for skin conditions in children. The center's research is particularly concentrated on addressing moderate to severe chronic plaque psoriasis in young patients.

• Psoriasis Area & Severity Index (PASI) Improvement
• Physician’s Global Assessment (PGA) Score Reduction

Through its pioneering work, the center is enhancing therapeutic strategies to improve the quality of life for pediatric patients with challenging dermatological conditions.

Specializing in allergy and immunology, the center is advancing the understanding and treatment of Chronic Spontaneous Urticaria (CSU). This condition, characterized by persistent hives, is being tackled through cutting-edge research and clinical trials.

• Urticaria Activity Score (UAS7) Reduction
• Improvement in Itch Severity Score (ISS7)
• Hives Severity Score (HSS7) Enhancement

The center's efforts are pivotal in developing new therapeutic options that offer relief and improved outcomes for patients suffering from chronic urticaria.